Trametinib shows promise for children with relapsed or refractory JMML
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic ...
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic ...
Momentary shifts in mood, even those lasting just a matter of seconds, profoundly alter the brain’s response to pleasurable experiences ...
A new partnership between education experts in Indonesia and the UK could transform lives by changing perceptions of disability. A ...
Why do politicians lie and deny when they are caught up in political scandal?Credit: Craig Chandler/University Communication and Marketing/University of Nebraska-Lincoln ...
The Science For the first time in history, scientists have measured radium’s bonding interactions with oxygen atoms in an organic ...
A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy ...
WASHINGTON – A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides ...
DETROIT — Alice Walker, Ph.D., assistant professor of chemistry in the College of Liberal Arts and Sciences at Wayne State ...
LAWRENCE — A partnership between scientists at the University of Kansas and collaborators in Europe, including war-torn Ukraine, will result ...
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE 12, 2024 EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine